During the submission process, you will be asked to select one topic for your abstract. The topic is the general theme under which the abstract will be reviewed and later assigned and published in the congress materials (if accepted).

Abstracts must be comprised of four distinct sections:

1. Introduction: Describes previous research and the rationale for the current study
2. Method: Describes how the study was conducted
3. Results: Describes the results of the study
4. Discussion/Conclusion: Summarize the study and discusses its implications

Please do not insert tables or images into the body of the abstract. They will need to be uploaded into JPG, PNG or GIF as figures.

All abstracts must be submitted electronically through the Congress management system

• Abstracts should be submitted in English. There is no fee for submission
• The abstract text body is limited to 3,000 characters, including spaces. A maximum of two figures can be included (in JPG, GIF or PNG of ideally 600 dpi and a maximum of 2MB). These will not count toward the word limit, nor will the information about authors, institutions and study groups. Ensure the figure have no surrounding white space and the text within is readable
• By submitting an abstract to IXA-CTRMS 2021 the submitter consents to having the abstract, if accepted, published in the online supplement of the Xenotransplantation and the Organogenesis Journals as well as in the Congress website and virtual platform
• Only registered presenters will have their accepted abstracts published
• It is the submitter responsibility to ensure that all co-authors approve of the abstract submission, publication, and potential presentation at IXA-CTRMS 2021
• Presenters from employees of commercial interests, selected for an oral or a poster presentation, may be required to submit additional information, including the presentation slides. Presenting content featuring clinical recommendations aligned to the business interests and/or products of the employer is strictly prohibited

Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

IXA-CTRMS 2021 welcomes the submission of abstracts previously presented at national, regional or international meetings in the two years preceding the congress. Encores must be documented as such at the time of submission. To be accepted, the abstract must include significant additional data from the previous presentation/s. Submission will not be permitted if a manuscript has been published.

IXA-CTRMS 2021 regards plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and, when identified, the abstract and any other abstracts submitted by the same author will be rejected. In addition, the submitting author’s profile and scholarship application, should one have been submitted, will also be cancelled.

To be eligible to submit an abstract, you must disclose that the author(s)/ scientist(s) have not violated any aspect of the following ethics statements:

• Declaration of Istanbul (DOI) ethics statement 
• Research conforms with the ethical statement on human research subjects, Helsinki Declaration of the World Medical Association
• The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003) for research involving human subjects -The Helsinki 
• The Transplantation Society ethics statement 

• All submitted abstracts will go through blind peer-review carried out by an international committee
• All abstracts will be reviewed by at least three international referees selected by the Scientific Program Committee
• Abstracts which do not meet the focus of the topic selected by the authors will be reassigned at the discretion of the Review Committee
• Abstracts will be assessed based the following criteria:
• Interest: Is the content original/important/relevant to our field?
• Novelty: How and to what extent are the findings likely to influence clinical or research practice, education or policy?
• Robustness and quality of the data: Are the methods/ methodological approach clearly described?  How confident is the reviewer in the strength/trustworthiness of the data and/or conclusions/discussion presented?
• Presentation and Clarity: The basic purpose of the research/project is clear

Abstracts may be submitted for either oral, poster, or oral/poster presentation (to be determined at the Committee’s discretion). Please note that space is very limited for oral abstract presentations.

Since there are limited slots for oral presentations within the program, a one oral presentation per registered presenter rule will be enforced. Should more than one abstract be accepted as an oral presentation, a co-author must be designated and register as the presenter.